Key result
GRAF1 expression drives muscle differentiation via RhoA down-regulation, while its depletion causes embryonic lethality.
GRAF1 is a critical GTPase-activating protein that regulates skeletal muscle maturation and myotube formation via RhoA down-regulation and BAR-dependent membrane remodeling.
Should not change clinical practice; leaves open GRAF1's therapeutic relevance in human myopathies.
Although RhoA activity is necessary for promoting myogenic mesenchymal stem cell fates, recent studies in cultured cells suggest that down-regulation of RhoA activity in specified myoblasts is required for subsequent differentiation and myotube formation. However, whether this phenomenon occurs in vivo and which Rho modifiers control these later events remain unclear. We found that expression of the Rho-GTPase-activating protein, GRAF1, was transiently up-regulated during myogenesis, and studies in C2C12 cells revealed that GRAF1 is necessary and sufficient for mediating RhoA down-regulation and inducing muscle differentiation. Moreover, forced expression of GRAF1 in pre-differentiated myoblasts drives robust muscle fusion by a process that requires GTPase-activating protein-dependent actin remodeling and BAR-dependent membrane binding or sculpting. Moreover, morpholino-based knockdown studies in Xenopus laevis determined that GRAF1 expression is critical for muscle development. GRAF1-depleted embryos exhibited elevated RhoA activity and defective myofibrillogenesis that resulted in progressive muscle degeneration, defective motility, and embryonic lethality. Our results are the first to identify a GTPase-activating protein that regulates muscle maturation and to highlight the functional importance of BAR domains in myotube formation.
No takes yet. Share an insight, caveat, or question.
Doherty et al. (2011) studied Muscle development and myogenesis. GRAF1 expression and depletion was evaluated on Muscle differentiation, myotube formation, and myofibrillogenesis. GRAF1 expression is necessary and sufficient for mediating RhoA down-regulation and inducing muscle differentiation, with its depletion leading to defective myofibrillogenesis and embryonic lethality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: